Of note, zinc treatment to AD fibroblasts restored HIPK2 binding activity to DNA, likely counteracting the proteasomal degradation, as previously reported [20] and thus suggesting that zinc was able to affect the dual role of HIPK2 as DNA co-repressor and as p53 activator. The gene discussed is TP53; the disease is Alzheimer disease.